Drugs that contain Crofelemer

1. List of Mytesi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7341744 NAPO PHARMS INC Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer
Jun, 2022

(9 months ago)

US9585868 NAPO PHARMS INC Methods and compositions for treating HIV-associated diarrhea
Oct, 2031

(8 years from now)

US8962680 NAPO PHARMS INC Methods and compositions for treating HIV-associated diarrhea
Oct, 2031

(8 years from now)

Market Authorisation Date: 31 December, 2012

Treatment: Symptomatic relief of non-infectious diarrhea

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

MYTESI family patents

9

United States

2

China

2

Japan

1

Portugal

1

Russia

1

Spain

1

Brazil

1

Colombia

1

Mexico

1

Peru

1

Hong Kong

1

South Africa

1

Canada

1

Hungary

1

Ukraine

1

Poland

1

Australia

1

Ecuador

1

Denmark

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic